BridgeBio Pharma, Inc. has announced the pricing of $500 million in convertible senior notes at a 1.75% interest rate, maturing in 2031, in a private offering aimed at qualified institutional buyers.
Despite many U.S. health systems seeing improved margins, some continue to be weighed down by long-term debt from investments in technology, large expansions, and asset transactions. Here are 28 ...
Bakkt Holdings (NYSE:BKKT) shares perked up 8.6% in Monday afternoon trading after the crypto infrastructure platform said it has eliminated all remaining long-term debt after redeeming its ...
MANSFIELD, Mass. and HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Samsonite Group S.A. (together with its consolidated subsidiaries, the "Company", "our", "us" or "we"; SEHK stock code: 1910), the world's ...
Yields for long-term debt from Japan and Germany to the UK and France rose on Monday as growing concern over widening fiscal deficits dented demand. The yield on Japan’s 30-year notes jumped the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback